A new era of allergy treatment

Scientists unveil the early molecular key to curing life-threatening allergies

05-Dec-2024 - In a landmark clinical study just published in Nature Communications, researchers from the Luxembourg Institute of Health (LIH), the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg, the Allergy Center Wiesbaden, Ulm University Hospital and the Brussels Vrije ...

Genetic screening before embryo transfer fails to improve the chance of a baby

06-Aug-2018 - The genetic screening of fertilised eggs for embryo selection in assisted reproduction makes no difference to live birth rates, according to results from the largest published study of its kind. Results from this multicentre randomised controlled trial, say the authors, confirm the "widely ...

New biotech company Confo Therapeutics launched by VIB and Vrije Universiteit Brussel

Capricorn Venture Partners leads 1st financing round of € 3 million

26-Jun-2015 - The establishment of Confo Therapeutics, a spin-off of VIB and Vrije Universiteit Brussel, was announced today. A consortium led by Capricorn Health-Tech Fund with the participation of Qbic and SOFI contributed € 3 million in the first institutional round of investment. These resources will be ...

New insights in survival strategies of bacteria

16-Sep-2014 - Bacteria are particularly ingenious when it comes to survival strategies. They often create a biofilm to protect themselves from a hostile environment, for example during treatment with antibiotics. A biofilm is a bacterial community that is surrounded by a protective slime capsule consisting of ...

Cancer turns out to be a protein aggregation disease

30-Mar-2011 - Protein aggregation, generally associated with Alzheimer’s and mad cows disease, turns out to play a significant role in cancer. In a paper published in Nature Chemical Biology, Frederic Rousseau and Joost Schymkowitz, both from VIB, Vrije Universiteit Brussel and K.U.Leuven describe that certain ...

Adrenaline receptor ‘frozen in action’ by VIB researchers

Discovery means breakthrough for the development of new drugs based on GPCR’s

14-Jan-2011 - Adrenaline, the hormone that prepares our body to fight or flight, acts on a hyperdynamic receptor. This molecule switches so fast between several positions, that it was impossible to image it. Until now. Scientists, including Jan Steyaert of VIB and the Vrije Universiteit Brussel in Belgium, and ...

New discovery brings hope to treatment of incurable blood cancer

20-Jul-2010 - Multiple myeloma is one of the most common blood cancers, and at present considered to be incurable. In a new study from Uppsala University, researchers now present a conceptually new model for the development and progression of multiple myeloma. The study was done in collaboration with Vrije ...

Flemish researchers provide the first experimental evidence of dynamic allostery in protein regulation

12-Jul-2010 - The brand-new Jean Jeener Bio-NMR Center at the VIB Department of Molecular and Cellular Interactions, Vrije Universiteit Brussel, has already played a role in a scientific breakthrough that made it into the journal Cell. Thanks to NMR technology, it is possible to determine the dynamic structure ...

Biologists discover bacterial defense mechanism against aggressive oxygen

23-Nov-2009 - Bacteria possess an ingenious mechanism for preventing oxygen from harming the building blocks of the cell. This is the new finding of a team of biologists that includes Joris Messens of VIB, a life sciences research institute in Flanders, Belgium, connected to the Vrije Universiteit Brussel. The ...

Bacteria pack their own demise

31-Jul-2009 - Numerous pathogens contain an ‘internal time bomb’, a deadly mechanism that can be used against them. After years of work, VIB researchers at the Vrije Universiteit Brussel (VUB) were able to determine the structure and operating mechanism of the proteins involved. This clears the road for ...